Axicabtagene ciloleucel in relapsed or refractory large B-cell lymphoma patients in complete metabolic response

Detalles Bibliográficos
Autores principales: Jallouk, Andrew P., Gouni, Sushanth, Westin, Jason, Feng, Lei, Mistry, Haleigh, Steiner, Raphael E., James, Jinsu, Noorani, Mansoor, Horowitz, Sandra, Puebla-Osorio, Nahum, Fayad, Luis E., Iyer, Swaminathan P., Hawkins, Misha, Flowers, Christopher R., Ahmed, Sairah, Nastoupil, Lo retta J, Kebriaei, Partow, Shpall, Elizabeth J., Neelapu, Sattva S., Nieto, Yago, Strati, Paolo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Fondazione Ferrata Storti 2022
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10071112/
https://www.ncbi.nlm.nih.gov/pubmed/36384251
http://dx.doi.org/10.3324/haematol.2022.281954

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10071112/
https://www.ncbi.nlm.nih.gov/pubmed/36384251
http://dx.doi.org/10.3324/haematol.2022.281954

Ejemplares similares